Cargando…
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine
Despite solid evidence of the success of rotavirus vaccines in saving children from fatal gastroenteritis, more than 82 million infants worldwide still lack access to a rotavirus vaccine. The main barriers to global rotavirus vaccine coverage include cost, manufacturing capacity and suboptimal effic...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062787/ https://www.ncbi.nlm.nih.gov/pubmed/33744044 http://dx.doi.org/10.1016/j.vaccine.2021.03.033 |